Last edition
News about "tumour cells "
Acepodia Doses First Patient in Phase 1 Trial of ACE723 for Liver Cancer
Acepodia has dosed the first patient in its Phase 1 clinical trial of ACE723, an investigational dual-payload ADC for unresectable or metastatic hepatocellular carcinoma.
Tumour Cells | 06/11/2026 | By News Bureau | 108
Silexion Reports Positive Findings for RNAi Candidate SIL204
Silexion Therapeutics reports new findings supporting the cellular uptake and gene-silencing mechanism of its investigational RNAi candidate SIL204.
Tumour Cells | 30/09/2026 | By News Bureau
AstraZeneca's investigational antibody-drug conjugate Sone-Ve demonstrated a significant overall survival benefit in the Phase 3 CLARITY-Gastric01 trial, marking a milestone in the development of targeted therapies for CLDN18.2-positive advanced gastric cancer.
Tumour Cells | 28/07/2026 | By News Bureau
Harbour BioMed Signs Strategic Collaboration with Lannacheng on Radionuclide Drug Conjugates
Harbour BioMed has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology to jointly advance the development of next-generation radionuclide drug conjugates, combining both companies’ resources and expertise to accelerate innovation in targeted radiopharmaceutical therapies.
Tumour Cells | 30/12/2025 | By News Bureau | 234
Roche Reports Positive Results from Phase III evERA Breast Cancer Study
Roche has announced positive results from the phase III evERA study evaluating its investigational oral selective oestrogen receptor degrader (SERD), giredestrant, in combination with everolimus in people with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer.
Tumour Cells | 24/09/2025 | By Dineshwori | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy